STRATEGIC MARKETING INNOVATIONS

Lobbying for CARDINAL POINT PARTNERS, LLC ON BEHALF OF TONIX PHARMACEUTICALS · Federal relations firm

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $20,000.00 income · posted Jul 18, 2025

Lobbying activity 3

Defense

Funding for biodefense and pandemic preparedness medical countermeasures

Health Issues

Funding for biodefense and pandemic preparedness medical countermeasures

Disaster Planning/Emergencies

Funding for biodefense and pandemic preparedness medical countermeasures

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.